Thijs Cohen Tervaert is a Junior Partner at INKEF. Thijs currently also serves on the board of TargED BioPharmaceuticals, Calypso Biotech, ViCentra, Audion Therapeutics, Aidence and Castor. Prior to INKEF, Thijs was a strategy consultant at the Boston Consulting Group with a focus on health care and technology. He worked on projects for pharmaceutical companies, hospitals and insurers. During a one year secondment, Thijs helped to establish the Amsterdam Health and Technology Institute in 2014. Thijs is a medical doctor and graduated at Leiden University. He has also co-authored several scientific papers.